Interrupting treatment of immune-suppressing medicines, doubles antibody response to COVID-19 booster vaccination: A major clinical trial, led by experts at the University of Nottingham working in partnership with several Universities and NHS hospitals, has found that by interrupting the treatment of vulnerable people on long-term immune supressing medicines for two weeks after a COVID-19 booster […]
Read More… from Immune-suppressing drugs and booster vaccination